40
Views
66
CrossRef citations to date
0
Altmetric
Original Article

Classification and Staging of Ph-negative Myeloproliferative Disorders by Histopathology from Bone Marrow Biopsies

, , , &
Pages 15-29 | Received 18 Mar 1996, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Umberto Gianelli, Claudia Vener, Paola Rafaniello Raviele, Alessia Moro, Federica Savi, Claudio Annaloro, Francesco Somalvico, Franca Radaelli, Vito Franco & Giorgio Lambertenghi Deliliers. (2006) Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology. Leukemia & Lymphoma 47:9, pages 1774-1781.
Read now
Juergen Thiele & Hans M. Kvasnicka. (2006) A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders. Leukemia & Lymphoma 47:3, pages 381-396.
Read now
Andreas Kreft, Birgitt Wiese, Martin Weiß, Harald Choritz, Thomas Buhr, Guntram BÜsche & Axel Georgii. (2004) Analysis of Risk Factors of the Evolution of Myelofibrosis in Pre-Fibrotic Chronic Idiopathic Myelofibrosis: A retrospective study based on follow up biopsies of 70 patients by using the RECPAM method. Leukemia & Lymphoma 45:3, pages 553-559.
Read now
J. J. Michiels, T. Barbui, G. Finazzi, S. M. Fuchtman, J. Kutti, J. D. Rain, R. T. Silver, A. Tefferi & J. Thiele. (2000) Diagnosis and Treatment of Polycythemia Vera and Possible Future Study Designs of the PVSG. Leukemia & Lymphoma 36:3-4, pages 239-253.
Read now
Andreas Kreft, Jeanette Reimann & Harald Choritz. (2000) Fibre Content and Cellularity of the Bone Marrow of the Iliac Crest, Vertebral Column and Sternum in Chronic Myeloproliferative Disorders. Leukemia & Lymphoma 38:1-2, pages 165-173.
Read now
Juergen Thiele, Hans Michael Kvasnicka, Volker Diehl, Robert Fischer & Jan Jacques Michiels. (1999) Clinicopathological Diagnosis and Differential Criteria of Thrombocythemias in Various Myeloproliferative Disorders by Histopathology, Histochemistry and Immunostaining from Bone Marrow Biopsies. Leukemia & Lymphoma 33:3-4, pages 207-218.
Read now

Articles from other publishers (58)

Emilia Krzemińska, Marta Robak, Jacek Treliński & Krzysztof Chojnowski. (2022) Assessment of megakaryocytes’ size and morphology in selected myeloproliferative neoplasms. Diagnostyka Laboratoryjna 57:4, pages 188-194.
Crossref
Pınar Tığlıoğlu, Murat Albayrak, Abdulkerim Yıldız, Mesut Tığlıoğlu, Buğra Sağlam, Merih Reis Aras, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk & Ümit Yavuz Malkan. (2022) Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience. Journal of Hematopathology 15:2, pages 83-93.
Crossref
S. Bartels, M. Faisal, G. Büsche, J. Schlue, B. Hasemeier, E. Schipper, J. Vogtmann, L. Westphal, U. Lehmann & H. Kreipe. (2020) Knochenmarkfibrose bei primärer Myelofibrose in Abhängigkeit von myelodysplasie- und altersassoziierten Mutationen der HämatopoeseBone marrow fibrosis in primary myelofibrosis in relation to myelodysplasia- and age-related mutations of hematopoietic cells. Der Pathologe 41:S2, pages 124-128.
Crossref
Michiels Jan Jacques, Lam King H, Kate Fibo Ten, Kim Dong-Wook, Kim Myungshin, Shuvaev Vasily, Valster Francisca, Potters Vincent, Schroyens Wilfried, Andreescu Mihaela, Trifa Adrian, Pich Achille & De Raeve Hendrik. (2020) Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels. International Journal of Bone Marrow Research 3:1, pages 001-020.
Crossref
Hans Kreipe. (2019) Klassifikation von MPN und chronischen myeloproliferativen Erkrankungen*. InFo Hämatologie + Onkologie 22:12, pages 12-20.
Crossref
Hans H. Kreipe. (2019) Klassifikation myeloproliferativer Neoplasien und chronischer myeloproliferativer ErkrankungenClassification of myeloproliferative neoplasms and chronic myeloproliferative disorders. Der Onkologe 25:11, pages 957-970.
Crossref
Jan Jacques Michiels, Yonggoo Kim, Myungshin Kim, Francisca Valster, Vincent Potters, Zwi Berneman, Alain Gadisseur, Wilfried Schroyens & Hendrik De Raeve. (2019) Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients. International Journal of Bone Marrow Research 2:1, pages 064-078.
Crossref
Jan Jacques Michiels & Hendrik De Raeve. (2019) The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018. International Journal of Bone Marrow Research, pages 027-050.
Crossref
Michiels Jan Jacques. (2019) European Clinical Laboratory, Molecular and Pathological (ECMP) criteria for prefibrotic JAK2V617F-Thrombocythemia and Polycythemia Vera versus MPL515- and CALR-Thrombocythemia and Myelofibrosis: From Dameshek to Michiels 1950-2018. International Journal of Bone Marrow Research 2:1, pages 001-017.
Crossref
Hans H. Kreipe. 2019. Pathologie. Pathologie 47 87 .
Tiziano Barbui, Jürgen Thiele, Alessandro M. Vannucchi & Ayalew Tefferi. (2016) Myeloproliferative neoplasms: Morphology and clinical practice. American Journal of Hematology 91:4, pages 430-433.
Crossref
T Barbui, J Thiele, A M Vannucchi & A Tefferi. (2015) Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis. Blood Cancer Journal 5:8, pages e337-e337.
Crossref
T Barbui, J Thiele, A M Vannucchi & A Tefferi. (2013) Rethinking the diagnostic criteria of polycythemia vera. Leukemia 28:6, pages 1191-1195.
Crossref
Wojciech Gorczyca. 2014. Atlas of Differential Diagnosis in Neoplastic Hematopathology, Third Edition. Atlas of Differential Diagnosis in Neoplastic Hematopathology, Third Edition 533 538 .
K. Hussein, G. Büsche, J. Schlue, U. Lehmann & H. Kreipe. (2012) Myeloproliferative NeoplasienMyeloproliferative neoplasms. Der Pathologe 33:6, pages 508-517.
Crossref
Tiziano BarbuiJürgen ThieleFrancesco PassamontiElisa RumiEmanuela BoveriMaria Luigia RandiIrene BertozziFilippo MarinoAlessandro M. VannucchiLisa PieriGiada RotunnoHeinz GisslingerBettina GisslingerLeonhard MüllauerGuido FinazziAlessandra CarobbioAndrea GianattiMarco Ruggeri, Ilaria Nichele, Emanuele D'Amore, Alessandro RambaldiAyalew Tefferi. (2012) Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. Blood 119:10, pages 2239-2241.
Crossref
Massimo Primignani. (2010) Portal vein thrombosis, revisited. Digestive and Liver Disease 42:3, pages 163-170.
Crossref
Juergen Thiele. (2009) Philadelphia Chromosome–Negative Chronic Myeloproliferative Disease. American Journal of Clinical Pathology 132:2, pages 261-280.
Crossref
Wojciech Gorczyca & Foxwell Nathan Emmons. 2008. Atlas of Differential Diagnosis in Neoplastic Hematopathology. Atlas of Differential Diagnosis in Neoplastic Hematopathology 542 566 .
Jean B Brière. (2007) Essential thrombocythemia. Orphanet Journal of Rare Diseases 2:1.
Crossref
Juergen Thiele, Attilio Orazi & Hans Kvasnicka. 2007. Myeloproliferative Disorders. Myeloproliferative Disorders 19 50 .
Ayalew Tefferi & James W Vardiman. (2007) The diagnostic interface between histology and molecular tests in myeloproliferative disorders. Current Opinion in Hematology 14:2, pages 115-122.
Crossref
J.J. Michiels, Z. Bernema, D. Van Bockstaele, H. De Raeve & W. Schroyens. (2007) Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF). Pathologie Biologie 55:2, pages 92-104.
Crossref
Jean Briere. (2007) Thrombocytémie essentielle. Apport de la mutation V617F de JAK2 pour la stratégie diagnostique, la physiopathologie et les modalités évolutives. Bulletin de l'Académie Nationale de Médecine 191:3, pages 535-548.
Crossref
Jürgen Thiele & Hans M. Kvasnicka. (2007) Myelofibrosis – What’s in a Name?. Pathobiology 74:2, pages 89-96.
Crossref
Hans Michael Kvasnicka & Jürgen Thiele. (2007) Classification of Ph-Negative Chronic Myeloproliferative Disorders – Morphology as the Yardstick of Classification. Pathobiology 74:2, pages 63-71.
Crossref
J. Thiele, H.M. Kvasnicka & J. Vardiman. (2006) Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: A forgotten pearl. Best Practice & Research Clinical Haematology 19:3, pages 413-437.
Crossref
Juergen Thiele & Hans Michael Kvasnicka. (2006) Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?. Current Hematologic Malignancy Reports 1:2, pages 87-92.
Crossref
J. Thiele & H. M. Kvasnicka. (2006) Grade of bone marrow fibrosis is associated with relevant hematological findings—a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Annals of Hematology 85:4, pages 226-232.
Crossref
J. Brière. (2006) Thrombocytémie essentielle. Critères du diagnostic. Stratification pronostique. Ébauche de stratégie thérapeutique. EMC - Hématologie 1:3, pages 1-19.
Crossref
Zbigniew Rudzki, Rafał Kawa, Krzysztof Okoñ, Ewa Szczygieł & Jerzy Stachura. (2005) Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool. Virchows Archiv 448:1, pages 59-67.
Crossref
U. Schuler & G. Ehninger. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie 2749 2775 .
Meinolf Suttorp. 2006. Pädiatrische Hämatologie und Onkologie. Pädiatrische Hämatologie und Onkologie 724 731 .
Dominique‐Charles Valla, Shiv K. Sarin, G. Barosi, Y.C. Chawla, Elwyn Elias, Harry Janssen, Massimo Primignani & Ian R. Wanless. 2006. Portal Hypertension IV. Portal Hypertension IV 285 327 .
Juergen Thiele, Hans Michael Kvasnicka & Attilio Orazi. (2005) Bone Marrow Histopathology in Myeloproliferative Disorders—Current Diagnostic Approach. Seminars in Hematology 42:4, pages 184-195.
Crossref
Juergen Thiele, Hans Michael Kvasnicka & Volker Diehl. (2005) Bone marrow features of diagnostic impact in erythrocytosis. Annals of Hematology 84:6, pages 362-367.
Crossref
Yasmine Chait, Bertrand Condat, Dominique Cazals-Hatem, Pierre Rufat, Sai Atmani, Driss Chaoui, Françoise Guilmin, Jean Jacques Kiladjian, Aurélie Plessier, Marie Hélène Denninger, Nicole Casadevall, Dominique Valla & Jean B. Brière. (2005) Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. British Journal of Haematology 129:4, pages 553-560.
Crossref
Jürgen Thiele, Hans Michael Kvasnicka & Volker Diehl. (2005) Initial (Latent) Polycythemia vera with Thrombocytosis Mimicking Essential Thrombocythemia. Acta Haematologica 113:4, pages 213-219.
Crossref
J Thiele, H M Kvasnicka, A Schmitt-Graeff & V Diehl. (2003) Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis. Histopathology 43:5, pages 470-479.
Crossref
J. Thiele & H. M. Kvasnicka. (2003) Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Annals of Hematology 82:3, pages 148-152.
Crossref
Thomas Buhr, Guntram Büsche, Harald Choritz, Florian Länger & Hans Kreipe. (2003) Evolution of Myelofibrosis in Chronic Idiopathic Myelofibrosis as Evidenced in Sequential Bone Marrow Biopsy Specimens. American Journal of Clinical Pathology 119:1, pages 152-158.
Crossref
Guntram BÜsche, MD, Harald Choritz, Florian LÄnger, MD, Hans Kreipe, MD & Thomas Buhr, MD. (2003) Evolution of Myelofibrosis in Chronic Idiopathic Myelofibrosis as Evidenced in Sequential Bone Marrow Biopsy Specimens. American Journal of Clinical Pathology 119:1, pages 152-158.
Crossref
Jan Jacques Michiels & Juergen Thiele. (2002) Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia). International Journal of Hematology 76:2, pages 133-145.
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt‐Graeff, Rudolph Zankovich & Volker Diehl. (2002) Follow‐up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patients. American Journal of Hematology 70:4, pages 283-291.
Crossref
J. Thiele, H.M. Kvasnicka, K. Muehlhausen, S. Walter, R. Zankovich & V. Diehl. (2001) Polycythemia rubra vera versus Secondary Polycythemias. A Clinicopathological Evaluation of Distinctive Features in 199 Patients. Pathology - Research and Practice 197:2, pages 77-84.
Crossref
J Briere & F Guilmin. (2001) Management of patients with essential thrombocythemia: current concepts and perspectives. Pathologie Biologie 49:2, pages 178-183.
Crossref
T.C Pearson & M Messinezy. (2001) Idiopathic erythrocytosis, diagnosis and clinical management. Pathologie Biologie 49:2, pages 170-177.
Crossref
J Thiele & H.M Kvasnicka. (2001) Clinicopathology and histochemistry on bone marrow biopsies in chronic myeloproliferative disorders – a clue to diagnosis and classification. Pathologie Biologie 49:2, pages 140-147.
Crossref
Joachim B?hm & Annette Schmitt-Gr?ff. (2000) Gelatinous bone marrow transformation in a case of idiopathic myelofibrosis: a morphological paradox. Pathology - Research and Practice 196:11, pages 775-779.
Crossref
Jan Jacques Michiels. (2016) Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia. Clinical and Applied Thrombosis/Hemostasis 5:4, pages 247-251.
Crossref
S. Duensing, A. Duensing, J. G. Meran, A. Kreft, G. Busche, A. Ganser & A. Georgii. (1999) Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders. Molecular Pathology 52:3, pages 146-150.
Crossref
W. Breuer, J. Darb?s, W. Hermanns & J. Thiele. (1999) Idiopathic myelofibrosis in a cat and in three dogs. Comparative Haematology International 9:1, pages 17-24.
Crossref
A. Georgii, G. Buesche & A. Kreft. (1998) 2 The histopathology of chronic myeloproliferative diseases. Baillière's Clinical Haematology 11:4, pages 721-749.
Crossref
T.C. Pearson. (1998) 1 Diagnosis and classification of erythrocytoses and thrombocytoses. Baillière's Clinical Haematology 11:4, pages 695-720.
Crossref
Ludwig Wilkens, Joelle Tchinda, Dagmar Burkhardt, Martina Nolte, Martin Werner & Axel Georgii. (1998) Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). Human Pathology 29:8, pages 833-839.
Crossref
M. Werner, M. Ewig, A. Nasarek, L. Wilkens, R. von Wasielewski, J. Tchinda & M. Nolte. (1997) Value of Fluorescence In Situ Hybridization for Detecting the bcr/abl Gene Fusion in Interphase Cells of Routine Bone Marrow Specimens. Diagnostic Molecular Pathology 6:5, pages 282-287.
Crossref
Jean Briere, Jean-Jacques Kiladjian & Edith Peynaud-Debayle. (1997) 4 Megakaryocytes and platelets in myeloproliferative disorders. Baillière's Clinical Haematology 10:1, pages 65-88.
Crossref
G. B�sche, H. Majewski, J. Schlu�, S. Delventhal, S. Baer-Henney, K. F. Vykoupil & A. Georgii. (1997) Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia. Virchows Archiv 430:2, pages 139-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.